4.2 Article

Type-I-error rate inflation in mixed models for repeated measures caused by ambiguous or incomplete model specifications

Journal

PHARMACEUTICAL STATISTICS
Volume -, Issue -, Pages -

Publisher

WILEY
DOI: 10.1002/pst.2328

Keywords

MMRM; model specification; multiplicity issue; simulation study; T1E rate inflation

Ask authors/readers for more resources

Pre-specification of the primary analysis model is essential to control the type-I-error rate in clinical trials, but the specified mixed models for repeated measures (MMRM) are often poorly defined. This investigation aims to quantify the inflation of the type-I-error rate caused by ambiguous model specifications. Simulated data from a clinical trial were analyzed using different MMRM clusters compatible with imprecise pre-specification. The results show a significant inflation of the type-I-error rate, indicating the importance of precise MMRM specifications in generating confirmatory evidence.
Pre-specification of the primary analysis model is a pre-requisite to control the family-wise type-I-error rate (T1E) at the intended level in confirmatory clinical trials. However, mixed models for repeated measures (MMRM) have been shown to be poorly specified in study protocols. The magnitude of a resulting T1E rate inflation is still unknown. This investigation aims to quantify the magnitude of the T1E rate inflation depending on the type and number of unspecified model items as well as different trial characteristics. We simulated a randomized, double-blind, parallel group, phase III clinical trial under the assumption that there is no treatment effect at any time point. The simulated data was analysed using different clusters, each including several MMRMs that are compatible with the imprecise pre-specification of the MMRM. T1E rates for each cluster were estimated. A significant T1E rate inflation could be shown for ambiguous model specifications with a maximum T1E rate of 7.6% [7.1%; 8.1%]. The results show that the magnitude of the T1E rate inflation depends on the type and number of unspecified model items as well as the sample size and allocation ratio. The imprecise specification of nuisance parameters may not lead to a significant T1E rate inflation. However, the results of this simulation study rather underestimate the true T1E rate inflation. In conclusion, imprecise MMRM specifications may lead to a substantial inflation of the T1E rate and can damage the ability to generate confirmatory evidence in pivotal clinical trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available